Selected article for: "disease severity and economic loss"
Author: Chen, Hao; Zhang, Xinyu; Liu, Wanjun; Xue, Mingshan; Liao, Chenxi; Huang, Zhifeng; Hu, Haisheng; Sun, Baoqing
Title: The role of serum specific- SARS-CoV-2 antibody in patients with COVID-19
  • Cord-id: l7uwtdxu
  • Document date: 2020_12_24
    • ID: l7uwtdxu
    Snippet: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for coronavirus disease 2019 (COVID-19), has rapidly spread, resulting in considerable casualties and serious economic loss worldwide. Disease severity and related symptoms markedly vary among individuals. A large number of patients present atypical symptoms, which represent a big challenge for early diagnosis and prompt infection source isolation. Currently, COVID-19 diagnosis predominantly depends on nucleic acid tests (
    Document: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for coronavirus disease 2019 (COVID-19), has rapidly spread, resulting in considerable casualties and serious economic loss worldwide. Disease severity and related symptoms markedly vary among individuals. A large number of patients present atypical symptoms, which represent a big challenge for early diagnosis and prompt infection source isolation. Currently, COVID-19 diagnosis predominantly depends on nucleic acid tests (NAT) for SARS-CoV-2 in respiratory specimens, but this method presents a high rate of false negative results. Therefore, serum antibody measurement has been rapidly developed as a supplementary method with the aim of improving diagnostic accuracy. Further, serum antibody levels might help to identify the infection stage, asymptomatic carriers, and patients with diverging severities and to monitor convalescent plasma therapy. In the current review, we aim to present comprehensive evidence to clarify the utility of SARS-CoV-2 antibodies measurement for COVID-19 diagnosis as a reference for use in the clinic.

    Search related documents:
    Co phrase search for related documents
    • acute respiratory distress syndrome and live virus: 1, 2, 3
    • acute respiratory distress syndrome and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress syndrome and liver disease severity: 1
    • acute respiratory distress syndrome and low mortality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress syndrome and low respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress syndrome and low respiratory tract: 1, 2
    • acute respiratory distress syndrome develop and liver disease: 1
    • acute respiratory distress syndrome develop and low mortality: 1
    • acute respiratory distress syndrome develop and low respiratory: 1, 2
    • acute stage infection and live virus: 1
    • acute stage infection and low respiratory: 1
    • live virus and low mortality: 1
    • live virus and low respiratory: 1, 2
    • live virus and low respiratory tract: 1, 2
    • liver disease and low mortality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • liver disease severity and low mortality: 1